posted on 2012-05-09, 00:00authored byAditya Kulkarni, Kyle DeFrees, Seok-Hee Hyun, David H. Thompson
A novel siRNA delivery vector has been developed, based
on the
self-assembly of monosubstituted cationic β-CD derivatives with
a poly(vinyl alcohol)MW27kD (PVA) main-chain polymer bearing poly(ethylene
glycol)MW2000 (PEG) and acid-labile cholesterol-modified (Chol) grafts
through an acid-sensitive benzylidene acetal linkage. These components
were investigated for their ability to form nanoparticles with siRNA
using two different assembly schemes, involving either precomplexation
of the pendant Chol-PVA-PEG polymer with the cationic β-CD derivatives
before siRNA condensation or siRNA condensation with the cationic
β-CD derivatives prior to addition of Chol-PVA-PEG to engage
host:guest complexation. The pendant polymer:amino-β-CD:siRNA
complexes were shown to form nanoparticles in the size range of 120–170
nm, with a slightly negative zeta potential. Cell viability studies
in CHO-GFP cells shows that these materials have 103-fold
lower cytotoxicities than 25 kD bPEI, while maintaining gene-silencing
efficiencies that are comparable to those of benchmark transfection
reagents such as bPEI and Lipofectamine 2000. These results suggest
that the degradable Chol-PVA-PEG polymer is able to self-assemble
in the presence of siRNA and cationic-β-CD to form nanoparticles
that are an effective and low-toxicity vehicle for delivering siRNA
cargo to target cells.